The FDA has approved Nexterone (amiodarone HCl, from Prism Pharmaceuticals) Injection, a cosolvent-free formulation of Amiodarone IV. The removal of the cosolvents, polysorbate 80 and benzyl alcohol, ...
KING OF PRUSSIA, Pa., Jan. 5 /PRNewswire/ -- Prism Pharmaceuticals announced today that the U.S. Food & Drug Administration (FDA) has approved the new drug application (NDA) for NEXTERONE(R) ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Catheter ablation benefited certain patients with MI and an implantable cardioverter ...
Background: A previously fit and healthy 30-year-old man reported experiencing palpitations accompanied by nausea, sweating and presyncope. These symptoms were found to be associated with episodes of ...
This ECG (Figure 1), recorded in the emergency room, shows a wide complex tachycardia at 205 bpm. Wide complex tachycardias are more likely to be ventricular tachycardia (VT) than supraventricular ...
In this Journal feature, information about a real patient is presented in stages (boldface type) to an expert clinician, who responds to the information, sharing his or her reasoning with the reader ...
Ventricular tachycardia (VT) after palliative repair of congenital heart disease is relatively rare. Despite this rarity, VT is a known cause of early, intermediate and late morbidity and mortality in ...
SCHAUMBURG, Ill., July 25 Sagent Pharmaceuticals, Inc., aprivately-held specialty pharmaceutical company, today announced that it haslaunched amiodarone HCl injection, USP, a class III antiarrhythmic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback